// Post a message

Replying to:

Reliable Cancer Therapies-MGHI parnership

Wednesday 9 January 2013

RCT (Reliable Cancer Therapies) have agreed to help financing the Fluvabrex Phase I trial that will investigate the tolerance and preliminary activity of fluvastatine and celecoxib in refractory low grade glioma. Recruitment shall start Q1-Q2 2013.

pre-moderation

This forum is pre-moderated: your contribution will only appear after being validated by an admin.

Who are you?
Your post

To create paragraphs, just leave blank lines.